{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:58:19Z","timestamp":1791035899483,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,3,4]],"date-time":"2013-03-04T00:00:00Z","timestamp":1362355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1475-2875-12-86","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T07:58:30Z","timestamp":1362470310000},"source":"Crossref","is-referenced-by-count":29,"title":["Experience and challenges from clinical trials with malaria vaccines in Africa"],"prefix":"10.1186","volume":"12","author":[{"given":"Grace","family":"Mwangoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhards","family":"Ogutu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Msambichaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tutu","family":"Mzee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahya","family":"Salim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubis","family":"Kafuruki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxmillian","family":"Mpina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seif","family":"Shekalaghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Abdulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,4]]},"reference":[{"key":"2683_CR1","volume-title":"World Malaria Report","author":"WHO","year":"2010","unstructured":"WHO: World Malaria Report. 2010, Geneva: World Health Organization, http:\/\/www.who.int\/malaria\/world_malaria_report_2010\/en\/ ,"},{"key":"2683_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1365-3156.2008.02076.x","volume":"13","author":"A Roca-Feltrer","year":"2008","unstructured":"Roca-Feltrer A, Carneiro I, Armstrong-Schellenberg JR: Estimates of the burden of malaria morbidity in Africa in children under the age of 5\u2009years. Trop Med Int Health. 2008, 13: 771-783. 10.1111\/j.1365-3156.2008.02076.x.","journal-title":"Trop Med Int Health"},{"key":"2683_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-1-4419-0981-7_12","volume":"659","author":"SJ Rogerson","year":"2010","unstructured":"Rogerson SJ: Malaria in pregnancy and the newborn. Adv Exp Med Biol. 2010, 659: 139-152. 10.1007\/978-1-4419-0981-7_12.","journal-title":"Adv Exp Med Biol"},{"key":"2683_CR4","first-page":"186","volume":"2","author":"J Schantz-Dunn","year":"2009","unstructured":"Schantz-Dunn J, Nour NM: Malaria and pregnancy: A global health perspective. Rev Obstet Gynecol. 2009, 2: 186-192.","journal-title":"Rev Obstet Gynecol"},{"key":"2683_CR5","doi-asserted-by":"publisher","first-page":"e1000398","DOI":"10.1371\/journal.pmed.1000398","volume":"8","author":"The malERA Consultative Group on Vaccines","year":"2011","unstructured":"The malERA Consultative Group on Vaccines: A research agenda for malaria eradication: vaccines. PLoS Med. 2011, 8: e1000398-","journal-title":"PLoS Med"},{"key":"2683_CR6","unstructured":"Malaria Vaccine Technology Roadmap Final Report. 2006, http:\/\/www.malariavaccine.org\/files\/Malaria_Vaccine_TRM_Final_000.pdf ,"},{"key":"2683_CR7","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1056\/NEJMoa1102287","volume":"365","author":"ST Agnandji","year":"2011","unstructured":"Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, Abossolo BP, Conzelmann C, Methogo BG, Doucka Y, Flamen A, Mordm\u00fcller B, Issifou S, Kremsner PG, Sacarlal J, Aide P, Lanaspa M, Aponte JJ, Nhamuave A, Quelhas D, Bassat Q, Mandjate S, Macete E, Alonso P, Abdulla S, Salim N, Juma O, Shomari M, Shubis K, Machera F, Hamad AS, Minja R, RTS,S Clinical Trials Partnership: First results of phase 3 trial of RTS,S\/AS01 malaria vaccine in African children. N Engl J Med. 2011, 365: 1863-1875.","journal-title":"N Engl J Med"},{"key":"2683_CR8","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1056\/NEJMoa1208394","volume":"367","author":"ST Agnandji","year":"2012","unstructured":"Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BG, Kabwende AL, Adegnika AA, Mordm\u00fcller B, Issifou S, Kremsner PG, Sacarlal J, Aide P, Lanaspa M, Aponte JJ, Machevo S, Acacio S, Bulo H, Sigauque B, Macete E, Alonso P, Abdulla S, Salim N, Minja R, Mpina M, Ahmed S, Ali AM, Mtoro AT, Hamad AS, Mutani P, Tanner M, RTS: A phase 3 trial of RTS,S\/AS01 malaria vaccine in African infants. N Engl J Med. 2012, 367: 2284-2295.","journal-title":"N Engl J Med"},{"key":"2683_CR9","volume-title":"Malaria Vaccine Rainbow Tables December","author":"WHO","year":"2012","unstructured":"WHO: Malaria Vaccine Rainbow Tables December. 2012, http:\/\/www.who.int\/vaccine_research\/links\/Rainbow\/en\/index.html ,"},{"key":"2683_CR10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.4161\/hv.9141","volume":"5","author":"R Chilengi","year":"2009","unstructured":"Chilengi R: Clinical development of malaria vaccines: should earlier trials be done in malaria endemic countries?. Hum Vaccin. 2009, 5: 627-","journal-title":"Hum Vaccin"},{"key":"2683_CR11","first-page":"83","volume":"9","author":"PL Alonso","year":"2006","unstructured":"Alonso PL: Malaria: deploying a candidate vaccine (RTS, S\/AS02A) for an old scourge of humankind. Int Microbiol. 2006, 9: 83-93.","journal-title":"Int Microbiol"},{"key":"2683_CR12","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.vaccine.2006.09.074","volume":"25","author":"MP Girad","year":"2007","unstructured":"Girad MP, Reed ZH, Friede M, Kieny MP: A review of human vaccine research and development: malaria. Vaccine. 2007, 25: 1567-1580. 10.1016\/j.vaccine.2006.09.074.","journal-title":"Vaccine"},{"key":"2683_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nri1746","volume":"6","author":"AVS Hill","year":"2006","unstructured":"Hill AVS: Pre-erythrocytic malaria vaccines:towards greater efficacy. Nat Rev Immunol. 2006, 6: 21-32. 10.1038\/nri1746.","journal-title":"Nat Rev Immunol"},{"key":"2683_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.clim.2008.01.012","volume":"127","author":"E Peduzzi","year":"2008","unstructured":"Peduzzi E, Westerfeld N, Zurbriggen R, Pluschke G, Daubenberger CA: Contribution of influenza immunity and virosomal-formulated synthetic peptide to cellular immune responses in a phase I subunit malaria vaccine trial. Clin Immunol. 2008, 127: 188-197. 10.1016\/j.clim.2008.01.012.","journal-title":"Clin Immunol"},{"key":"2683_CR15","first-page":"409","volume":"41","author":"AA Holder","year":"1999","unstructured":"Holder AA, Guevara Patino JA, Uthaipibull C, Syed SE, Ling IT, Scott-Finnigan T, Blackman MJ: Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. Parassitologia. 1999, 41: 409-414.","journal-title":"Parassitologia"},{"key":"2683_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1590\/S0074-02761992000700038","volume":"3","author":"Bouharoun-Tayoun H Druilhe P","year":"1992","unstructured":"Bouharoun-Tayoun H Druilhe P: Antibodies in falciparum malaria: what matters most, quantity or quality?. Mem Inst Oswaldo Cruz 87 Suppl. 1992, 3: 229-234.","journal-title":"Mem Inst Oswaldo Cruz 87 Suppl"},{"key":"2683_CR17","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1084\/jem.172.6.1633","volume":"172","author":"H Bouharoun-Tayoun","year":"1990","unstructured":"Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P: Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med. 1990, 172: 1633-1641. 10.1084\/jem.172.6.1633.","journal-title":"J Exp Med"},{"key":"2683_CR18","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1371\/journal.pmed.0040320","volume":"4","author":"C Roussilhon","year":"2007","unstructured":"Roussilhon C, Oeuvray C, Muller-Graf C, Tall A, Rogier C, Trape JF, Theisen M, Balde A, Perignon JL, Druilhe P: Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med. 2007, 4: e320-10.1371\/journal.pmed.0040320.","journal-title":"PLoS Med"},{"key":"2683_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1046\/j.0141-9838.2001.00440.x","volume":"24","author":"FM Ndungu","year":"2002","unstructured":"Ndungu FM, Bull PC, Ross A, BS Lowe BS, Kabiru E, Marsh K: Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2. Parasite Immunol. 2002, 24: 77-82. 10.1046\/j.0141-9838.2001.00440.x.","journal-title":"Parasite Immunol"},{"key":"2683_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1574-695X.1996.tb00282.x","volume":"14","author":"BF Chumpitazi","year":"1999","unstructured":"Chumpitazi BF, Lepers JP, Simon J, Deloron P: IgG1 and IgG2 antibody responses to Plasmodium falciparum exoantigens correlate inversely and positively, respectively, to the number of malaria attacks. FEMS Immunol Med Microbiol. 1999, 14: 151-158.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2683_CR21","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4269\/ajtmh.1994.51.720","volume":"51","author":"AJ Luty","year":"1994","unstructured":"Luty AJ, Mayombo J, Lekoulou F, Mshana R: Immunologic responses to soluble exoantigens of Plasmodium falciparum in Gabonese children exposed to continuous intense infection. AmJTrop Med Hyg. 1994, 51: 720-729.","journal-title":"AmJTrop Med Hyg"},{"key":"2683_CR22","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/IAI.65.8.3271-3276.1997","volume":"65","author":"JL Sarthou","year":"1997","unstructured":"Sarthou JL, Angel G, Aribot G, Rogier C, Dieye A, Toure BA, Diatta B, Seignot P, Roussilhon C: Prognostic value of anti-Plasmodium falciparum-specific immunoglobulin G3, cytokines, and their soluble receptors in West African patients with severe malaria. Infect Immun. 1997, 65: 3271-3276.","journal-title":"Infect Immun"},{"key":"2683_CR23","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1128\/IAI.64.7.2716-2723.1996","volume":"64","author":"YP Shi","year":"1996","unstructured":"Shi YP, Sayed U, Qari SH, Roberts JM, Udhayakumar V, Oloo AJ, Hawley WA, Kaslow DC, Nahlen BL, Lal AA: Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infect Immun. 1996, 64: 2716-2723.","journal-title":"Infect Immun"},{"key":"2683_CR24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4269\/ajtmh.1998.58.406","volume":"58","author":"RR Taylor","year":"1998","unstructured":"Taylor RR, Allen SJ, Greenwood BM, Riley EM: IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. AmJTrop Med Hyg. 1998, 58: 406-413.","journal-title":"AmJTrop Med Hyg"},{"key":"2683_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.vaccine.2008.10.025","volume":"27","author":"NC Iriemenam","year":"2009","unstructured":"Iriemenam NC, Khirelsied AH, Nasr A, ElGhazali G, Giha HA, Elhassan A-E, Agab-Aldour AA, Montgomery SM, Anders RF, Theisen M, Troye-Blomberg M, Elbashir MI, Berzins K: Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan. Vaccine. 2009, 27: 62-71. 10.1016\/j.vaccine.2008.10.025.","journal-title":"Vaccine"},{"key":"2683_CR26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1128\/IAI.01147-07","volume":"76","author":"I Nebie","year":"2008","unstructured":"Nebie I, Diarra A, Ouedraogo A, Soulama I, Bougouma EC, Tiono AB, Konate AT, Chilengi R, Theisen M, Dodoo D, Remarque E, Bosomprah S, Milligan P, Sirima SB: Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. Infect Immun. 2008, 76: 759-766. 10.1128\/IAI.01147-07.","journal-title":"Infect Immun"},{"key":"2683_CR27","doi-asserted-by":"publisher","first-page":"e52870","DOI":"10.1371\/journal.pone.0052870","volume":"7","author":"FM Ndungu","year":"2012","unstructured":"Ndungu FM, Mwacharo J, Kimani D, Kai O, Moris P, Jongert E, Vekemans J, Olotu A, Bejon P: A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S\/AS01E. PLoS One. 2012, 7: e52870-10.1371\/journal.pone.0052870.","journal-title":"PLoS One"},{"key":"2683_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1086\/600120","volume":"200","author":"KE Kester","year":"2009","unstructured":"Kester KE, Cummings JF, Ofori-Anyinam O, Ockenhouse CF, Krzych U, Moris P, Schwenk R, Nielsen RA, Debebe Z, Pinelis E, Juompan L, Williams J, Dowler M, Stewart VA, Wirtz RA, Dubois MC, Lievens M, Cohen J, Ballou WR, Heppner DG: Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS, S\/AS01B and RTS, S\/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J Infect Dis. 2009, 200: 337-346. 10.1086\/600120.","journal-title":"J Infect Dis"},{"key":"2683_CR29","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1086\/318534","volume":"183","author":"KE Kester","year":"2001","unstructured":"Kester KE, McKinney DA, Tornieporth N, Ockenhouse CF, Heppner DG, Hall T, Krzych U, Delchambre M, Voss G, Dowler MG, Palensky J, Wittes J, Cohen J, Ballou WR: Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria. J Infect Dis. 2001, 183: 640-647. 10.1086\/318534.","journal-title":"J Infect Dis"},{"key":"2683_CR30","doi-asserted-by":"publisher","first-page":"e5165","DOI":"10.1371\/journal.pone.0005165","volume":"4","author":"C Guinovart","year":"2009","unstructured":"Guinovart C, Aponte JJ, Sacarlal J, Aide P, Leach A, Bassat Q, Macete E, Doba\u00f1o C, Lievens M, Loucq C, Ballou WR, Cohen J, Alonso PL: Insights into long-lasting protection induced by RTS, S\/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children. PLoS One. 2009, 4: e5165-10.1371\/journal.pone.0005165.","journal-title":"PLoS One"},{"key":"2683_CR31","doi-asserted-by":"publisher","first-page":"e25786","DOI":"10.1371\/journal.pone.0025786","volume":"6","author":"A Olotu","year":"2011","unstructured":"Olotu A, Moris P, Mwacharo J, Vekemans J, Kimani D, Janssens M, Kai O, Jongert E, Lievens M, Leach A, Villafana T, Savarese B, Marsh K, Cohen J, Bejon P: Circumsporozoite-specific T cell responses in children vaccinated with RTS, S\/AS01E and protection against P. falciparum clinical malaria. PLoS One. 2011, 6: e25786-10.1371\/journal.pone.0025786.","journal-title":"PLoS One"},{"key":"2683_CR32","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S1473-3099(11)70100-1","volume":"11","author":"KP Asante","year":"2011","unstructured":"Asante KP, Abdulla S, Agnandji S, Lyimo J, Vekemans J, Soulanoudjingar S, Owusu R, Shomari M, Leach A, Jongert E, Salim N, Fernandes JF, Dosoo D, Chikawe M, Issifou S, Osei-Kwakye K, Lievens M, Paricek M, Moller T, Apanga S, Mwangoka G, Dubois MC, Madi T, Kwara E, Minja R, Hounkpatin AB, Boahen O, Kayan K, Adjei G, Chandramohan D, Carter T: Safety and efficacy of the RTS, S\/AS01(E) candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19\u2009month follow-up of a randomised, open-label, phase 2 trial. Lancet Infect Dis. 2011, 11: 741-749. 10.1016\/S1473-3099(11)70100-1.","journal-title":"Lancet Infect Dis"},{"key":"2683_CR33","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","volume":"364","author":"PL Alonso","year":"2004","unstructured":"Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Milman J, Mandomando I, Spiessens B, Guinovart C, Espasa M, Bassat Q, Aide P, Ofori-Anyinam O, Navia MM, Corachan S, Ceuppens M, Dubois MC, Demoitie MA, Dubovsky F, Menendez C, Tornieporth N, Ballou WR, Thompson R, Cohen J: Efficacy of the RTS, S\/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet. 2004, 364: 1411-1420. 10.1016\/S0140-6736(04)17223-1.","journal-title":"Lancet"},{"key":"2683_CR34","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1016\/j.vaccine.2010.05.033","volume":"28","author":"S Casares","year":"2010","unstructured":"Casares S, Brumeanu TD, Richie TL: The RTS, S malaria vaccine. Vaccine. 2010, 28: 4880-4888. 10.1016\/j.vaccine.2010.05.033.","journal-title":"Vaccine"},{"key":"2683_CR35","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMe1111777","volume":"365","author":"NJ White","year":"2011","unstructured":"White NJ: A vaccine for malaria. N Engl J Med. 2011, 365: 1926-1928. 10.1056\/NEJMe1111777.","journal-title":"N Engl J Med"},{"key":"2683_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1475-2875-11-11","volume":"11","author":"L Schwartz","year":"2012","unstructured":"Schwartz L, Brown GV, Genton B, Moorthy VS: A review of malaria vaccine clinical projects based on the WHO rainbow table. Malar J. 2012, 11: 11-10.1186\/1475-2875-11-11.","journal-title":"Malar J"},{"key":"2683_CR37","doi-asserted-by":"publisher","first-page":"e1493","DOI":"10.1371\/journal.pone.0001493","volume":"3","author":"FM Thompson","year":"2008","unstructured":"Thompson FM, Porter DW, Okitsu SL, Westerfeld N, Vogel D, Todryk S, Poulton I, Correa S, Hutchings C, Berthoud T, Dunachie S, Andrews L, Williams JL, Sinden R, Gilbert SC, Pluschke G, Zurbriggen R, Hill AV: Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial. PLoS One. 2008, 3: e1493-10.1371\/journal.pone.0001493.","journal-title":"PLoS One"},{"key":"2683_CR38","doi-asserted-by":"publisher","first-page":"e22273","DOI":"10.1371\/journal.pone.0022273","volume":"6","author":"PG Cech","year":"2011","unstructured":"Cech PG, Aebi T, Abdallah MS, Mpina M, Machunda EB, Westerfeld N, Stoffel SA, Zurbriggen R, Pluschke G, Tanner M, Daubenberger C, Genton B, Abdulla S: Virosome-formulated Plasmodium falciparum AMA-1 & CSP derived peptides as malaria vaccine: randomized phase 1b trial in semi-immune adults & children. PLoS One. 2011, 6: e22273-10.1371\/journal.pone.0022273.","journal-title":"PLoS One"},{"key":"2683_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4161\/hv.6.1.10396","volume":"6","author":"SL Hoffman","year":"2010","unstructured":"Hoffman SL, Billingsley PF, James E, Richman A, Loyevsky M, Li T, Chakravarty S, Gunasekera A, Chattopadhyay R, Li M, Stafford R, Ahumada A, Epstein JE, Sedegah M, Reyes S, Richie TL, Lyke KE, Edelman R, Laurens MB, Plowe CV, Sim BK: Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccin. 2010, 6: 97-106. 10.4161\/hv.6.1.10396.","journal-title":"Hum Vaccin"},{"key":"2683_CR40","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1056\/NEJMoa0805832","volume":"361","author":"M Roestenberg","year":"2009","unstructured":"Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ, Teelen K, Arens T, Spaarman L, Roeffen W, Snounou G, Renia L, Hermsen CC, Sauerwein R, d van V: Protection against a malaria challenge by sporozoite inoculation. N Engl J Med. 2009, 361: 468-477. 10.1056\/NEJMoa0805832.","journal-title":"N Engl J Med"},{"key":"2683_CR41","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/S0140-6736(11)60360-7","volume":"377","author":"M Roestenberg","year":"2011","unstructured":"Roestenberg M, Teirlinck AC, McCall MB, Teelen K, Makamdop KN, Wiersma J, Arens T, Beckers P, van Gemert G, van de Vegte-Bolmer M, van der Ven AJ, Luty AJ, Hermsen CC, Sauerwein RW: Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet. 2011, 377: 1770-1776. 10.1016\/S0140-6736(11)60360-7.","journal-title":"Lancet"},{"key":"2683_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1475-2875-6-107","volume":"6","author":"K Miura","year":"2007","unstructured":"Miura K, Keister DB, Muratova OV, Sattabongkot J, Long CA, Saul A: Transmission-blocking activity induced by malaria vaccine candidates Pfs25\/Pvs25 is a direct and predictable function of antibody titer. Malar J. 2007, 6: 107-10.1186\/1475-2875-6-107.","journal-title":"Malar J"},{"key":"2683_CR43","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1016\/j.vaccine.2007.01.085","volume":"25","author":"V Moorthy","year":"2007","unstructured":"Moorthy V, Reed Z, Smith PG: Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation. Vaccine. 2007, 25: 5115-5123. 10.1016\/j.vaccine.2007.01.085.","journal-title":"Vaccine"},{"key":"2683_CR44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/1475-2875-10-223","volume":"10","author":"C Swysen","year":"2011","unstructured":"Swysen C, Vekemans J, Bruls M, Oyakhirome S, Drakeley C, Kremsner P, Greenwood B, Ofori-Anyinam O, Okech B, Villafana T, Carter T, Savarese B, Duse A, Reijman A, Ingram C, Frean J, Ogutu B: Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S\/AS01 candidate malaria vaccine. Malar J. 2011, 10: 223-10.1186\/1475-2875-10-223.","journal-title":"Malar J"},{"key":"2683_CR45","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1002\/sim.4780132206","volume":"13","author":"T Smith","year":"1994","unstructured":"Smith T, Schellenberg JA, Hayes R: Attributable fraction estimates and case definitions for malaria in endemic areas. Stat Med. 1994, 13: 2345-2358. 10.1002\/sim.4780132206.","journal-title":"Stat Med"},{"key":"2683_CR46","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/S0140-6736(10)61269-X","volume":"376","author":"B Moonen","year":"2010","unstructured":"Moonen B, Cohen JM, Snow RW, Slutsker L, Drakeley C, Smith DL, Abeyasinghe RR, Rodriguez MH, Maharaj R, Tanner M, Targett G: Operational strategies to achieve and maintain malaria elimination. Lancet. 2010, 376: 1592-1603. 10.1016\/S0140-6736(10)61269-X.","journal-title":"Lancet"},{"key":"2683_CR47","doi-asserted-by":"publisher","first-page":"e1000406","DOI":"10.1371\/journal.pmed.1000406","volume":"8","author":"PL Alonso","year":"2011","unstructured":"Alonso PL, Brown G, Arevalo-Herrera M, Binka F, Chitnis C, Collins F, Doumbo OK, Greenwood B, Hall BF, MM Levine MM, Mendis K, Newman RD, Plowe CV, Rodriguez MH, Sinden R, Slutsker L, Tanner M: A research agenda to underpin malaria eradication. PLoS Med. 2011, 8: e1000406-10.1371\/journal.pmed.1000406.","journal-title":"PLoS Med"},{"key":"2683_CR48","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4269\/ajtmh.2004.71.80","volume":"71","author":"T Smith","year":"2004","unstructured":"Smith T, Killeen G, Lengeler C, Tanner M: Relationships between the outcome of Plasmodium falciparum infection and the intensity of transmission in Africa. AmJTrop Med Hyg. 2004, 71: 80-86.","journal-title":"AmJTrop Med Hyg"},{"key":"2683_CR49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4269\/ajtmh.2006.75.2_suppl.0750011","volume":"75","author":"T Smith","year":"2006","unstructured":"Smith T, Maire N, Dietz K, Killeen GF, Vounatsou P, Molineaux L, Tanner M: Relationship between the entomologic inoculation rate and the force of infection for Plasmodium falciparum malaria. AmJTrop Med Hyg. 2006, 75: 11-18.","journal-title":"AmJTrop Med Hyg"},{"key":"2683_CR50","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/intqhc\/14.6.439","volume":"14","author":"HL Smits","year":"2002","unstructured":"Smits HL, Leatherman S, Berwick DM: Quality improvement in the developing world. Int J Qual Health Care. 2002, 14: 439-440. 10.1093\/intqhc\/14.6.439.","journal-title":"Int J Qual Health Care"},{"key":"2683_CR51","first-page":"265","volume":"11","author":"V Gardette","year":"2007","unstructured":"Gardette V, Coley N, Toulza O, Andrieu S: Attrition in geriatric research: how important is it and how should it be dealt with?. J Nutr Health Aging. 2007, 11: 265-268.","journal-title":"J Nutr Health Aging"},{"key":"2683_CR52","first-page":"361","volume":"22","author":"Eakin, Bull SS, Riley K,Reeves MM, Gutierrez S, McLaughlin P","year":"2007","unstructured":"Eakin, Bull SS, Riley K,Reeves MM, Gutierrez S, McLaughlin P: Recruitment and retention of Latinos in a primary care-based physical activity and diet trial: The Resources for Health study. Health Educ Res. 2007, 22: 361-371.","journal-title":"Health Educ Res"},{"key":"2683_CR53","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1126\/science.1109773","volume":"307","author":"OK Doumbo","year":"2005","unstructured":"Doumbo OK: Global voices of science. It takes a village: medical research and ethics in Mali. Science. 2005, 307: 679-681. 10.1126\/science.1109773.","journal-title":"Science"},{"key":"2683_CR54","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1086\/430707","volume":"41","author":"DA Diallo","year":"2005","unstructured":"Diallo DA, Doumbo OK, Plowe CV, Wellems TE, Emanuel EJ, Hurst SA: Community permission for medical research in developing countries. Clin Infect Dis. 2005, 41: 255-259. 10.1086\/430707.","journal-title":"Clin Infect Dis"},{"key":"2683_CR55","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1371\/journal.pmed.0040095","volume":"4","author":"DA Chokshi","year":"2007","unstructured":"Chokshi DA, Thera MA, Parker M, Diakite M, Makani J, Kwiatkowski DP, Doumbo OK: Valid consent for genomic epidemiology in developing countries. PLoS Med. 2007, 4: e95-10.1371\/journal.pmed.0040095.","journal-title":"PLoS Med"},{"key":"2683_CR56","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1371\/journal.pmed.0040273","volume":"4","author":"PO Tindana","year":"2007","unstructured":"Tindana PO, Singh JA, Tracy CS, Upshur RE, Daar AS, Singer PA, Frohlich J, Lavery JV: Grand challenges in global health: community engagement in research in developing countries. PLoS Med. 2007, 4: e273-10.1371\/journal.pmed.0040273.","journal-title":"PLoS Med"},{"key":"2683_CR57","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1478-4505-7-16","volume":"7","author":"K Shubis","year":"2009","unstructured":"Shubis K, Juma O, Sharifu R, Burgess B, Abdulla S: Challenges of establishing a Community Advisory Board (CAB) in a low-income, low-resource setting: experiences from Bagamoyo. Tanzania. Health Res Policy Syst. 2009, 7: 16-10.1186\/1478-4505-7-16.","journal-title":"Health Res Policy Syst"},{"key":"2683_CR58","unstructured":"Safety and Immunogenicity of 30 and 100 \u00ecg of GMZ2 in Gabonese Children Aged 1\u20135 Years. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00703066 ,"},{"key":"2683_CR59","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1475-2875-9-86","volume":"9","author":"A Nyika","year":"2010","unstructured":"Nyika A, Chilengi R, Ishengoma D, Mtenga S, Thera MA, Sissoko MS, Lusingu J, Tiono AB, Doumbo O, Sirima SB, Lemnge M, Kilama WL: Engaging diverse communities participating in clinical trials: case examples from across Africa. Malar J. 2010, 9: 86-10.1186\/1475-2875-9-86.","journal-title":"Malar J"},{"key":"2683_CR60","unstructured":"Ifakara Health Institute (IHI). http:\/\/www.ihi.or.tz ,"},{"key":"2683_CR61","unstructured":"New Malaria Clinical Trial Site Inaugurated at Bagamoyo. Tanzania, http:\/\/www.mmv.org\/newsroom\/news\/new-malaria-clinical-trial-site-inaugurated-bagamoyo-tanzania ,"},{"key":"2683_CR62","unstructured":"Malaria Clinical Trial Site Inaugurated at Bagamoyo. 2009, Tanzania, http:\/\/www.mmv.org\/newsroom\/news ,"},{"key":"2683_CR63","doi-asserted-by":"publisher","first-page":"e619","DOI":"10.1371\/journal.pntd.0000619","volume":"4","author":"TA Lang","year":"2010","unstructured":"Lang TA, White NJ, Tran HT, Farrar JJ, Day NP, Fitzpatrick R, Angus BJ, Denis E, Merson L, Cheah PY, Chilengi R, Kimutai R, Marsh K: Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated. PLoS Negl Tro. Dis. 2010, 4: e619-10.1371\/journal.pntd.0000619.","journal-title":"PLoS Negl Tro. Dis"},{"key":"2683_CR64","unstructured":"European and Developing Countries Clinical Trials Partnership (EDCTP). http:\/\/www.edctp.org\/uploads\/tx_viprojects\/Project_Profile_-_CB_Ethics-COHRED_41303_Carel_IJsselmuiden.pdf ,"},{"key":"2683_CR65","unstructured":"Novartis Annual Report. 2009, http:\/\/www.novartis.pt\/downloads\/imprensa\/publicacoes\/en\/Novartis_Annual_Report_2009_EN.pdf ,"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-12-86.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1475-2875-12-86\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-12-86.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T05:31:37Z","timestamp":1595482297000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-12-86"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,4]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2683"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-12-86","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,4]]},"article-number":"86"}}